The impact of changes in opioid dependency treatment upon COVID-19 transmission in Sydney, Australia: a retrospective longitudinal observational study by Benjamin T. Trevitt, Victoria Hayes, Rachel Deacon, Llewellyn Mills, Apo Demirkol, Nicholas Lintzeris

Connect to this object online.

Medical cannabis use in Australia: consumer experiences from the online cannabis as medicine survey 2020 (CAMS-20) by Nicholas Lintzeris, Llewellyn Mills, Sarah V. Abelev, Anastasia Suraev, Jonathon C. Arnold, Iain S. McGregor

Connect to this object online.

Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder by Llewellyn Mills, Adrian Dunlop, Mark Montebello, Jan Copeland, Raimondo Bruno, Meryem Jefferies, Iain Mcgregor, Nicholas Lintzeris

Connect to this object online.

Driving-related behaviors, attitudes, and perceptions among Australian medical cannabis users: results from the CAMS 20 survey by Thomas R. Arkell, Sarah V. Abelev, Llewellyn Mills, Anastasia Suraev, Jonathon C. Arnold, Nicholas Lintzeris, Iain S. McGregor

Connect to this object online.

Medical cannabis use in the Australian community following introduction of legal access: the 2018-2019 Online Cross-Sectional Cannabis as Medicine Survey (CAMS-18) by Nicholas Lintzeris, Llewellyn Mills, Anastasia Suraev, Maria Bravo, Thomas Arkell, Jonathon C. Arnold, Melissa J. Benson, Iain S. McGregor

Connect to this object online.

Medical cannabis use in Australia seven years after legalisation: findings from the online Cannabis as Medicine Survey 2022-2023 (CAMS-22) by Llewellyn Mills, Jonathon C. Arnold, Anastasia Suraev, Sarah V. Abelev, Cilla Zhou, Thomas R. Arkell, Iain S. McGregor, Nicholas Lintzeris

Connect to this object online.